29914956-figure-01 (29914956 Figure 01)
Fosinopril Sodium
Product Images NDC 50436-0274
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 50436-0274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
29914956-figure-02 (29914956 Figure 02)
This is a table that shows the incidence of clinical adverse events in a placebo-controlled trial for hypertension medication. The medication in question is Fosinopril Sodium, and the trial compares the incidence of adverse events between patients taking the medication and those taking a placebo. The adverse events included in the table are coughing, dizziness, nausea and vomiting, and the table shows the number of patients who experienced each event, as well as the number of patients who discontinued the medication due to each event.*
29914956-figure-03 (29914956 Figure 03)
The text describes the incidence of adverse events in a placebo-controlled trial for heart failure, where N=373. The events include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, and diarrhea, along with the corresponding incidence rates and discontinuation rates.*
29914956-figure-04 (29914956 Figure 04)
Label Image (50436 0274)
This is information about a medication called Fosinopril. It is a tablet containing 40mg of Sodium produced by Camber. The packaging includes 30 tablets. The remaining text is not-readable or is gibberish.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
